Chronic treatment with a water-soluble extract from the culture medium of Ganoderma lucidum mycelia prevents apoptosis and necroptosis in hypoxia/ischemia-induced injury of type 2 diabetic mouse brain

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Xuan, Meiyan ^a   Okazaki, Mari ^a   Iwata, Naohiro ^a   Asano, Satoshi ^b   Kamiuchi, Shinya ^a   Matsuzaki, Hirokazu ^a   Sakamoto, Takeshi ^a   Miyano, Yoshiyuki ^c   Iizuka, Hiroshi ^c   Hibino, Yasuhide ^a  

^a JOSAI UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c Noda Shokukin kogyo Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GANODERMA LUCIDUM EXTRACT; MEMBRANE PROTEIN; MESSENGER RNA; RECEPTOR INTERACTING PROTEIN KINASE 3; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY LIGATION; ARTICLE; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CELL VACUOLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CULTURE MEDIUM; GANODERMA LUCIDUM; HISTOCHEMISTRY; LONG TERM CARE; MALE; MOUSE; MYCELIUM; NECROPTOSIS; NERVE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; TUNEL ASSAY;

EID: 84928484993     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/865986     Document Type: Article

References (54)

1. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, "Global estimates of the prevalence of diabetes for 2010 and 2030, " Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4-14, 2010.
2. M. A. Potenza, S. Gagliardi, C. Nacci, M. R. Carratu, and M. Montagnani, "Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets, " Current Medicinal Chemistry, vol. 16, no. 1, pp. 94-112, 2009.
3. S. E. Capes, D. Hunt, K. Malmberg, P. Pathak, and H. C. Gerstein, "Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview, " Stroke, vol. 32, no. 10, pp. 2426-2432, 2001.
4. W. A. Pulsinelli, D. E. Levy, B. Sigsbee, P. Scherer, and F. Plum, "Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus, " The American Journal of Medicine, vol. 74, no. 4, pp. 540-544, 1983.
5. A. Tuttolomondo, A. Pinto, G. Salemi et al., "Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome, " Nutrition, Metabolism and Cardiovascular Diseases, vol. 18, no. 2, pp. 152-157, 2008.
6. Z.-G. Li, M. Britton, A. A. F. Sima, and J. C. Dunbar, "Diabetes enhances apoptosis induced by cerebral ischemia, " Life Sciences, vol. 76, no. 3, pp. 249-262, 2004.
7. N. N. Rizk, J. Rafols, and J. C. Dunbar, "Cerebral ischemia induced apoptosis and necrosis in normal and diabetic rats, " Brain Research, vol. 1053, no. 1-2, pp. 1-9, 2005.
8. N. Iwata, M. Okazaki, M. Xuan, S. Kamiuchi, H. Matsuzaki, and Y. Hibino, "Orally administrated ascorbic acid suppresses neuronal damage and modifies expression of SVCT2 and GLUT1 in the brain of diabetic rats with cerebral ischemiareperfusion, " Nutrients, vol. 6, no. 4, pp. 1554-1577, 2014.
9. K. Tureyen, K. Bowen, J. Liang, R. J. Dempsey, and R. Vemuganti, "Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia, " Journal of Neurochemistry, vol. 116, no. 4, pp. 499-507, 2011.
10. A. Sakata, M. Mogi, J. Iwanami et al., "Female exhibited severe cognitive impairment in type 2 diabetes mellitus mice, " Life Sciences, vol. 86, no. 17-18, pp. 638-645, 2010.
11. R. Tsuruta, M. Fujita, T. Ono et al., "Hyperglycemia enhances excessive superoxide anion radical generation, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats, " Brain Research, vol. 1309, pp. 155-163, 2010.
12. M. Y. Donath and S. E. Shoelson, "Type 2 diabetes as an inflammatory disease, " Nature Reviews Immunology, vol. 11, no. 2, pp. 98-107, 2011.
13. G. Fantuzzi, "Adipose tissue, adipokines, and inflammation, " Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 911-920, 2005.
14. A. Saito, C. M. Maier, P. Narasimhan et al., "Oxidative stress and neuronal death/survival signaling in cerebral ischemia, " Molecular Neurobiology, vol. 31, no. 1-3, pp. 105-116, 2005.
15. K. P. Doyle, R. P. Simon, and M. P. Stenzel-Poore, "Mechanisms of ischemic brain damage, " Neuropharmacology, vol. 55, no. 3, pp. 310-318, 2008.
16. K.-A. Hossmann, "Viability thresholds and the penumbra of focal ischemia, " Annals of Neurology, vol. 36, no. 4, pp. 557-565, 1994.
17. C. Li and R. M. Jackson, "Reactive species mechanisms of cellular hypoxia-reoxygenation injury, " American Journal of Physiology: Cell Physiology, vol. 282, no. 2, pp. C227-C241, 2002.
18. S. Cuzzocrea, D. P. Riley, A. P. Caputi, and D. Salvemini, "Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury, " Pharmacological Reviews, vol. 53, no. 1, pp. 135-159, 2001.
19. A. Degterev, Z. Huang, M. Boyce et al., "Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury, " Nature chemical biology, vol. 1, no. 2, pp. 112-119, 2005.
20. X. Xu, K.-W. Chua, C. C. Chua, C.-F. Liu, R. C. Hamdy, and B. H. L. Chua, "Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury, " Brain Research, vol. 1355, pp. 189-194, 2010.
21. Y. Wang, H. Wang, Y. Tao, S. Zhang, J. Wang, and X. Feng, "Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury, " Neuroscience, vol. 266, pp. 91-101, 2014.
22. J. W. Upton, W. J. Kaiser, and E. S. Mocarski, "Virus inhibition of RIP3-dependent necrosis, " Cell Host and Microbe, vol. 7, no. 4, pp. 302-313, 2010.
23. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, and G. Kroemer, "Molecular mechanisms of necroptosis: an ordered cellular explosion, " Nature ReviewsMolecular Cell Biology, vol. 11, no. 10, pp. 700-714, 2010.
24. S. Challa and F. K.-M. Chan, "Going up in flames: necrotic cell injury and inflammatory diseases, " Cellular and Molecular Life Sciences, vol. 67, no. 19, pp. 3241-3253, 2010.
25. P. Vandenabeele, W. Declercq, F. Van Herreweghe, and T. V. Berghe, "The role of the kinases RIP1 and RIP3 in TNF-induced necrosis, " Science Signaling, vol. 3, no. 115, 2010.
26. Y. S. Cho, S. Challa, D. Moquin et al., "Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation, " Cell, vol. 137, no. 6, pp. 1112-1123, 2009.
27. S. He, L. Wang, L. Miao et al., "Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α, " Cell, vol. 137, no. 6, pp. 1100-1111, 2009.
28. M. Vieira, J. Fernandes, L. Carreto et al., "Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3, " Neurobiology of Disease, vol. 68, pp. 26-36, 2014.
29. D.-W. Zhang, J. Shao, J. Lin et al., "RIP3, an energymetabolism regulator that switches TNF-induced cell death from apoptosis to necrosis, " Science, vol. 325, no. 5938, pp. 332-336, 2009.
30. B. Sunyer, S. Patil, C. Frischer, H. Hoeger, and G. Lubec, "Straindependent effects of cognitive enhancers in the mouse, " Amino Acids, vol. 34, no. 3, pp. 485-495, 2008.
31. B. S. Sanodiya, G. S. Thakur, R. K. Baghel, G. B. K. S. Prasad, and P. S. Bisen, "Ganoderma lucidum: a potent pharmacological macrofungus, " Current Pharmaceutical Biotechnology, vol. 10, no. 8, pp. 717-742, 2009.
32. N. Iwata, M. Okazaki, C. Kasahara et al., "Protective effects of a water-soluble extract from culture medium of Ganoderma lucidum mycelia against neuronal damage after cerebral ischemia/reperfusion in diabetic rats, " Journal of the Japanese Society for Food Science and Technology, vol. 61, pp. 119-127, 2008.
33. N. Iwata, M. Okazaki, R. Nakano et al., "Diabetes-mediated exacerbation of neuronal damage and inflammation after cerebral ischemia in rat: protective effects of water-soluble extract from culture medium of Ganoderma lucidum mycelia, " in Advances in the Preclinical Study of Ischemic Stroke, M. Balestrino, Ed., chapter 11, pp. 215-240, InTech, 2012.
34. H. Matsuzaki, Y. Shimizu, N. Iwata et al., "Antidepressant-like effects of a water-soluble extract from the culture medium of Ganoderma lucidum mycelia in rats, " BMC Complementary and Alternative Medicine, vol. 13, article 370, 2013.
35. S. J. Vannucci, L. B. Willing, S. Goto et al., "Experimental stroke in the female diabetic, db/db, mouse, " Journal of Cerebral Blood Flow and Metabolism, vol. 21, no. 1, pp. 52-60, 2001.
36. T. Tsubokawa, V. Jadhav, I. Solaroglu, Y. Shiokawa, Y. Konishi, and J. H. Zhang, "Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats, " Stroke, vol. 38, no. 3, pp. 1057-1062, 2007.
37. J. B. Bederson, L. H. Pitts, S. M. Germano, M. C. Nishimura, R. L. Davis, and H. M. Bartkowski, "Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats, " Stroke, vol. 17, no. 6, pp. 1304-1308, 1986.
38. R. Trotti, M. Carratelli, and M. Barbieri, "Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum, " Panminerva Medica, vol. 44, no. 1, pp. 37-40, 2002.
39. S. Dayal, E. Arning, T. Bottiglieri et al., "Cerebral vascular dysfunctionmediated by superoxide in hyperhomocysteinemic mice, " Stroke, vol. 35, no. 8, pp. 1957-1962, 2004.
40. S. J. Guyenet, H. T. Nguyen, B. H. Hwang, M. W. Schwartz, D. G. Baskin, and J. P. Thaler, "High-fat diet feeding causes rapid, nonapoptotic cleavage of caspase-3 in astrocytes, " Brain Research, vol. 1512, pp. 97-105, 2013.
41. J.-Q. Song, X. Teng, Y. Cai, C.-S. Tang, and Y.-F. Qi, "Activation of Akt/GSK-3β signaling pathway is involved in intermedin1-53 protection against myocardial apoptosis induced by ischemia/reperfusion, " Apoptosis, vol. 14, no. 11, pp. 1299-1307, 2009.
42. N. Kubo, Y. Myojin, F. Shimamoto et al., "Protective effects of a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia and Agaricus blazei murill against X-irradiation in B6C3F1 mice: increased small intestinal crypt survival and prolongation of average time to animal death, " International journal of molecular medicine, vol. 15, no. 3, pp. 401-406, 2005.
43. I. Nakagawa, Y. Hibino, Y. Ohashi, and N. Sugano, "Augmentation of cytolytic activity of mouse splenic cells by a heteroglycan-protein fraction from culture medium of Ganoderma lucidum (Rei-shi) mycelia, " Biotherapy, vol. 13, no. 5, pp. 513-515, 1999.
44. M. Okazaki, A. Tanaka, Y. Hatta et al., "Antioxidant properties of a water-soluble extract from culture medium of Ganoderma lucidum (Rei-shi) mycelia and antidiabetic effects in streptozotocin-treated mice, " Japanese Journal of Complementary and Alternative Medicine, vol. 5, pp. 209-218, 2008.
45. P.-A. Li, G.-J. Liu, Q. P. He, R. A. Floyd, and B. K. Siesjö, "Production of hydroxyl free radical by brain tissues in hyperglycemic rats subjected to transient forebrain ischemia, " Free Radical Biology and Medicine, vol. 27, no. 9-10, pp. 1033-1040, 1999.
46. A. P. Rolo and C. M. Palmeira, "Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress, " Toxicology and Applied Pharmacology, vol. 212, no. 2, pp. 167-178, 2006.
47. K. Niizuma, H. Yoshioka, H. Chen et al., "Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia, " Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1802, no. 1, pp. 92-99, 2010.
48. D. Brenner and T. W. Mak, "Mitochondrial cell death effectors, " Current Opinion in Cell Biology, vol. 21, no. 6, pp. 871-877, 2009.
49. Y. Tsujimoto and S. Shimizu, "Role of the mitochondrial membrane permeability transition in cell death, " Apoptosis, vol. 12, no. 5, pp. 835-840, 2007.
50. O. Micheau and J. Tschopp, "Induction of TNF receptor Imediated apoptosis via two sequential signaling complexes, " Cell, vol. 114, no. 2, pp. 181-190, 2003.
51. G. Faraco, S. Fossati, M. E. Bianchi et al., "High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo, " Journal of Neurochemistry, vol. 103, no. 2, pp. 590-603, 2007.
52. W. X. Zhang, Q. L. Zhang, W. Deng et al., "Neuroprotective effect of pretreatment with Ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus, " Neural Regeneration Research, vol. 9, no. 15, pp. 1446-1452, 2014.
53. C.-Y. Lin, Y.-H. Chen, H.-Y. Hsu et al., "Ganoderma lucidum polysaccharides attenuate endotoxin-induced intercellular cell adhesionmolecule-1 expression in cultured smoothmuscle cells and in the neointima in mice, " Journal of Agricultural and Food Chemistry, vol. 58, no. 17, pp. 9563-9571, 2010.
54. S. Dudhgaonkar, A. Thyagarajan, and D. Sliva, "Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum, " International Immunopharmacology, vol. 9, no. 11, pp. 1272-1280, 2009.